Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: just my opinion re: J3 royalties or contingencies...

just my opinion re: J3 royalties or contingencies...

posted on May 13, 2008 09:11AM

IMHO, yesterday's letter, when read in conjunction with the "plain English" of the following statement from RG in April, forecloses the possibility of any sort of additional income from the settlement:

"I will not, in the limited context of this letter, recount all the information contained in our April 9, 2008 earnings release, which fully reflects the financial results of all transactions announced prior to the end of January 2008."

This is only my opinion, but the marketplace for PTSC stock (such as it is) seems to agree. That represents pretty strong confirmation to me. If it happens when (not if) the USPTO revalidates the patents, great. But I'm not counting on it, and imho it takes a Ouija board to reach that conclusion in the face of the plain English we've seen thus far.

I'm with ease: from prior experience (and this one) parsing PR's and shareholder letters for hidden meanings and coded messages is a dangerous pastime. I also agree with Bush's comment yesterday that the insider trading announcement by JT was directed to potential insider sales, not purchases, resulting from knowledge of the J3 settlement. 20-20 hindsight, of course.

Still hoping for success here, but not holding my breath...


Share
New Message
Please login to post a reply